Recombinant Insulin Human
Novo Nordisk Pharmatech supplies recombinant insulin for cell culture processes by providing excellence at every step of the supply chain.
Metisafe
Metisafe provides pre-engineered and custom cleanroom facilities for drug development applications.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Novo Nordisk Pharmatech
Novo Nordisk Pharmatech is a Novo Nordisk company specialising in...
About
Novo Nordisk Pharmatech is a Novo Nordisk company specialising in the supply of ingredients for the biopharmaceutical and pharmaceutical industries, such as human insulin for cell culture media and current good manufacturing practices (cGMP) manufactured quaternary ammonium compounds (usually referred to as quats), including benzalkonium chloride, cetrimide, and cetrimonium bromide.
Products
FeF® Strong Cetrimide Solution 40% BP Pharma With Isopropyl Alcohol
Also known as Cetrimide, Cetrimoni Bromidum and Tetradecyl trimethyl ammonium bromide (TTAB), FeF® Strong Cetrimide Solution 40% BP Pharma with isopropyl alcohol (CAS No. 1119-97-7) consists of around 20% dodecyl trimethyl ammonium bromide and approcimately 80% trimethyl tetradecyl ammonium bromide, as well as approximately 7.5% volume by volume (v/v) isopropyl alcohol.
FollowMake an Enquiry
-
SHL
SHL provides design, development and manufacturing services for advanced drug...
About
SHL provides design, development and manufacturing services for advanced drug delivery systems.
FollowMake an Enquiry
-
OnAsset Intelligence
OnAsset provides asset visibility solutions with products that actively track...
About
OnAsset provides asset visibility solutions with products that actively track and monitor supply chains worldwide.
Products
Hybrid Solutions
We can provide customised and enhanced supply chain monitoring solutions to support your specific needs.
Mobile Applications and Enterprise API
The OnAsset team is experienced in building iOS and Android apps to deliver the exact user interface needed for your organisation.
FollowMake an Enquiry
